Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Doctors show bias in pacemaker choice:

This article was originally published in Clinica

Executive Summary

Younger, white, male Medicare patients in large, urban, private or western US hospitals are more likely to receive dual chamber pacemakers. The trend has nothing to do with clinical characteristics but the choice of dual- or single-chamber pacing has a significant effect on survival, according to a paper in the AHA journal, Circulation (February 15th). The authors studied physician practice patterns in a random sample of 36,312 Medicare patients who received pacemakers between 1988 and 1990. After two years the death rate in those with dual-chamber devices was 22.3%, while those with single chamber pacemakers was 28.9%.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT090519

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel